Cuu Long Pharmaceutical JSC

10
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DCL1
VND
41,850.00
-3150 (-7.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
13,21,589.00
13,06,797.00
11,43,946.00
10,15,685.00
7,03,634.00
6,71,246.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
13,21,589.00
13,06,797.00
11,43,946.00
10,15,685.00
7,03,634.00
6,71,246.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,20,550.00
1,20,461.00
1,25,358.00
1,32,956.00
1,21,564.00
1,14,617.00
Operating Expenses
49,128.00
25,494.00
30,530.00
36,283.00
36,476.00
34,471.00
General and Administration Expenses
1,40,235.00
1,40,266.00
1,34,824.00
1,50,090.00
1,20,531.00
1,35,987.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
12,63,103.00
12,46,967.00
10,73,220.00
8,87,400.00
6,16,853.00
6,23,342.00
Operating Profit (PBDIT) excl Other Income
58,485.00
59,830.00
70,725.00
1,28,285.00
86,780.00
47,904.00
Other Income
25,354.00
34,441.00
37,915.00
49,539.00
59,979.00
72,511.00
Operating Profit (PBDIT)
1,37,255.00
1,32,528.00
1,46,919.00
2,15,959.00
1,81,033.00
1,48,695.00
Interest
49,128.00
25,494.00
30,530.00
36,283.00
36,476.00
34,471.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
53,416.00
38,257.00
38,278.00
38,134.00
34,273.00
28,279.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
34,711.00
68,776.00
78,110.00
1,41,541.00
1,10,284.00
85,944.00
Provision for Tax
14,620.00
14,631.00
15,976.00
28,627.00
22,527.00
17,016.00
Profit After Tax
19,516.00
53,571.00
61,717.00
1,11,640.00
85,960.00
66,391.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
267.20
733.44
844.97
1,591.22
1,494.98
966.21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 1.13% vs 14.24% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -2.25% vs -15.41% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 92.70% vs -16.50% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is -63.57% vs -13.20% in Dec 2024

Compare Profit and Loss Results of Cuu Long Pharmaceutical JSC
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
No of Months
12
12
Operating Income
13,21,589.00
20,73,187.00
-7,51,598.00
-36.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
13,21,589.00
20,73,187.00
-7,51,598.00
-36.25%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1,20,550.00
2,63,570.00
-1,43,020.00
-54.26%
Operating Expenses
49,128.00
96,506.00
-47,378.00
-49.09%
General and Administration Expenses
1,40,235.00
2,78,608.00
-1,38,373.00
-49.67%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
12,63,103.00
20,47,846.00
-7,84,743.00
-38.32%
Operating Profit (PBDIT) excl Other Income
58,485.00
25,341.00
33,144.00
130.79%
Other Income
25,354.00
1,75,012.00
-1,49,658.00
-85.51%
Operating Profit (PBDIT)
1,37,255.00
3,57,561.00
-2,20,306.00
-61.61%
Interest
49,128.00
96,506.00
-47,378.00
-49.09%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
53,416.00
1,57,207.00
-1,03,791.00
-66.02%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
34,711.00
1,03,847.00
-69,136.00
-66.57%
Provision for Tax
14,620.00
46,294.00
-31,674.00
-68.42%
Profit After Tax
19,516.00
39,983.00
-20,467.00
-51.19%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
267.1991
117.6226
149.58
127.17%
Profit And Loss - Net Sales
Net Sales 13,21,589.11 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 1.13% vs 14.24% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58,485.41 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -2.25% vs -15.41% in Dec 2024

Profit And Loss - Interest
Interest 49,128.55 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 92.70% vs -16.50% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 19,516.50 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -63.57% vs -13.20% in Dec 2024